Showing 1 - 7 results of 7 for search 'Brian A Telfer', query time: 0.03s Refine Results
  1. 1
    Noninvasive Monitoring of Simulated Hemorrhage and Whole Blood Resuscitation

    Noninvasive Monitoring of Simulated Hemorrhage and Whole Blood Resuscitation by Jay F. Gupta, Saaid H. Arshad, Brian A. Telfer, Eric J. Snider, Victor A. Convertino

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Microbubble Contrast Agents Improve Detection of Active Hemorrhage

    Microbubble Contrast Agents Improve Detection of Active Hemorrhage by Scott Schoen Jr, Alexis Prasov, Ion Candel, Saaid Arshad, Mark Ottensmeyer, Theodore T. Pierce, Laura J. Brattain, Brian A. Telfer, Anthony E. Samir

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment

    Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment by Emma J Searle, Brian A Telfer, Debayan Mukherjee, Duncan M Forster, Barry R Davies, Kaye J Williams, Ian J Stratford, Tim M Illidge

    Published 2017-10-01
    Get full text
    Article
  4. 4
    AI-Enabled, Ultrasound-Guided Handheld Robotic Device for Femoral Vascular Access

    AI-Enabled, Ultrasound-Guided Handheld Robotic Device for Femoral Vascular Access by Laura J. Brattain, Theodore T. Pierce, Lars A. Gjesteby, Matthew R. Johnson, Nancy D. DeLosa, Joshua S. Werblin, Jay F. Gupta, Arinc Ozturk, Xiaohong Wang, Qian Li, Brian A. Telfer, Anthony E. Samir

    Published 2021-12-01
    Get full text
    Article
  5. 5
    The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.

    The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy. by Simon J A van Kuijk, Roben G Gieling, Raymon Niemans, Natasja G Lieuwes, Rianne Biemans, Brian A Telfer, Guido R M M Haenen, Ala Yaromina, Philippe Lambin, Ludwig J Dubois, Kaye J Williams

    Published 2016-01-01
    Get full text
    Article
  6. 6
    Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself.

    Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. by Cian M McCrudden, Martin G O'Rourke, Kim E Cherry, Hiu-Fung Yuen, Declan O'Rourke, Muhammad Babur, Brian A Telfer, Huw D Thomas, Patrick Keane, Thiagarajan Nambirajan, Chris Hagan, Joe M O'Sullivan, Chris Shaw, Kaye J Williams, Nicola J Curtin, David G Hirst, Tracy Robson

    Published 2015-01-01
    Get full text
    Article
  7. 7
    PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models

    PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models by Chun Wai Wong, Christos Evangelou, Kieran N. Sefton, Rotem Leshem, Wei Zhang, Vishaka Gopalan, Sorayut Chattrakarn, Macarena Lucia Fernandez Carro, Erez Uzuner, Holly Mole, Daniel J. Wilcock, Michael P. Smith, Kleita Sergiou, Brian A. Telfer, Dervla T. Isaac, Chang Liu, Nicholas R. Perl, Kerrie Marie, Paul Lorigan, Kaye J. Williams, Patricia E. Rao, Raghavendar T. Nagaraju, Mario Niepel, Adam F. L. Hurlstone

    Published 2023-09-01
    Get full text
    Article

Search Tools: